Inflammasomopathies
|
CAPS
|
Cryopyrin/NLRP3
|
PRR for ROS, K+ efflux, cathepsin B detection
|
Metabolic syndrome:
|
Gout [42]
|
Atherosclerosis [43]
|
Type 2 diabetes [44]
|
Neurodegenerative disease:
|
Alzheimer’s disease [45, 46]
|
Parkinson’s disease [47]
|
Amyotrophic lateral sclerosis [48]
|
Multiple sclerosis [49]
|
Infections and aberrant inflammatory responses:
|
Septic shock syndrome [50, 51]
|
Ischemic diseases:
|
Myocardial infarction [52]
|
Stroke [53]
|
NAIAD
|
NLRP1
|
PRR against Anthrax toxin detection
|
Infections and aberrant inflammatory responses:
|
Anthrax lethal toxin [54]
|
Neurodegenerative disease:
|
Alzheimer’s disease [46]
|
Ischemic diseases:
|
Stroke [53]
|
NLRP12-AD
|
NLRP12
|
PRR for Yersinia pestis detection
|
Infections and aberrant inflammatory responses:
|
Yersinia pestis [55]
|
Plasmodium chabaudi [56]
|
NF-κB inhibition
|
Regulation of inflammation:
|
Salmonella typhimurium [57]
|
Brucella abortus [58]
|
TRAPS
|
TNFRSF1A
|
TNF receptor
|
Infections and aberrant inflammatory responses:
|
Tumor necrosis factor [59]
|
APLAID
|
PLCγ2
|
Cleavage PIP to DAG
|
Immunodeficiency:
|
Common variable immunodeficiency [60]
|
PLCγ2-associated antibody deficiency and immune dysregulation syndrome (PLAID) [60]
|
Familial cold autoinflammatory syndrome 3 [60]
|
Neurodegenerative disease:
|
Alzheimer’s disease [61, 62]
|
Lewy body dementia [62]
|
Frontotemporal dementia [62]
|
FMF
|
Pyrin
|
Virulence sensor
|
Infections and aberrant inflammatory responses:
|
Yersinia pestis infection [63]
|
PFIT
|
WDR1
|
Actin assembly, leukocyte migration
|
Infections and aberrant inflammatory responses:
|
Listeria monocytogenes dissemination [64]
|
PAAND
|
Pyrin
|
Virulence sensor
|
Infections and aberrant inflammatory responses:
|
Yersinia pestis infection [63]
|
PAPA syndrome
|
PSTPIP1/CD2BP1
|
Pyrin regulation
|
Immunodeficiency:
|
Common variable immunodeficiency [65]
|
MKD
|
MVK
|
Lipid metabolism
|
Metabolic syndrome:
|
Atherosclerosis [66]
|
NLRC4 inflammasomopathies
|
NLRC4
|
PRR for flagellin detection
|
Infections and aberrant inflammatory responses:
|
Pseudomonas aeruginosa infection [67]
|
Macrophage activation syndrome (MAS) [68]
|
Relopathies
|
BS/EOS
|
NOD2
|
PRR for MDP
|
Infections and aberrant inflammatory responses:
|
Mycobacterium tuberculosis infection [69]
|
HA20
|
A20/TNFAIP3A
|
Deubiquitinating for NF-κB regulation
|
Infections and aberrant inflammatory responses:
|
Systemic lupus erythematosus (SLE) [70]
|
Rheumatoid arthritis [71]
|
IAALUCD
|
LUBAC
|
Ubiquitinating for NF-κB regulation
|
Infections and aberrant inflammatory responses:
|
HOIL-1/ RBCK1
|
Salmonella enterica infection [72]
|
HOIP/RNF31
|
Legionella pneumophila infection [72]
|
SHARPIN
|
Shigella flexneri infection [72]
|
ORAS
|
OTULIN
|
Deubiquitinating for NF-κB regulation
|
Infections and aberrant inflammatory responses:
|
Salmonella Typhimurium infection [73]
|
IL-1 receptor-related autoinflammatory diseases:
|
DIRA
|
IL1RN
|
IL-1 receptor inhibitor
|
Infections and aberrant inflammatory responses:
|
Inflammasomopathies [74]
|
Interferonopathies
|
AGS
|
RNASEH2
|
RNase activity against viral RNA
|
Infections and aberrant inflammatory responses:
|
SLE and other autoimmune diseases [75, 76]
|
Cervical cancer via human papilloma virus [77]
|
SAMHD1
|
dNTPase activity against viral RNA/DNA
|
Epstein-Barr virus infection [78]
|
Human immunodeficiency virus infection [79]
|
ADAR1
|
Viral RNA processing
|
Hepatitis B virus infection [80]
|
Marburg and Ebola virus [81]
|
MDA5/IFIH1
|
PRR for viral RNA detection
|
Paramyxovirus infection [82]
|
Picornavirus infection [83]
|
SAVI
|
STING/TMEM173
|
PRR for viral DNA/RNA detection
|
Infections and aberrant inflammatory responses:
|
SLE and other autoimmune diseases [76]
|
ANCA-associated vasculitis [84]
|
Herpes simplex virus infection [85]
|
COPA syndrome
|
αCOP
|
Transport vesicles between Golgi to ER
|
Infections and aberrant inflammatory responses:
|
Interstitial lung disease [86]
|
Capillaritis [87]
|
PRAAS/NNS/CANDLE
|
PSMB3,4,8,9
|
Proteasome for antigen processing
|
Infections and aberrant inflammatory responses:
|
SLE and other autoimmune disease [87, 88]
|
Cytomegalovirus infection [89]
|
Hepatitis B virus infection [90]
|
Influenza virus infection [91]
|
POMP
|
Proteasome chaperone
|
Infections and aberrant inflammatory responses:
|
Psoriasis [92]
|
Human papilloma virus infection [93]
|
SMS
|
MDA5/IFIH1
|
PRR for viral RNA detection
|
Infections and aberrant inflammatory responses:
|
SLE and other autoimmune diseases [75, 76, 94]
|
Paramyxovirus infection [82]
|
Picornavirus infection [83]
|
RIG-I
|
PRR for viral RNA detection
|
Infections and aberrant inflammatory responses:
|
SLE and other autoimmune diseases [95]
|
Paramyxovirus infection [83]
|